STOCK TITAN

Aleafia Health Inc. - ALEAF STOCK NEWS

Welcome to our dedicated news page for Aleafia Health (Ticker: ALEAF), a resource for investors and traders seeking the latest updates and insights on Aleafia Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aleafia Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aleafia Health's position in the market.

Rhea-AI Summary
Aleafia Health Inc. announces Red White & Bloom Brands Inc. as the successful bidder in the sale and investment solicitation process. The Court-approved sale includes the acquisition of certain assets and share subscription agreement. Aleafia will also sell its Grimsby facility to a third-party purchaser. Court approval for the sale transactions will be sought on October 27, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Aleafia Health and its subsidiaries have been granted an order from the Ontario Superior Court of Justice to restructure their business and financial affairs. The company terminated a letter agreement with Red White & Bloom Brands Inc. and is currently in breach of certain covenants under a loan agreement. The board of directors determined that seeking creditor protection under the CCAA was in the best interest of the company and stakeholders. The Initial Order provides for a stay of proceedings, debtor-in-possession financing, and the appointment of a monitor. The company intends to launch a sale and investment solicitation process for its business and assets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) and Aleafia Health Inc. (TSX: AH and OTCQB: ALEAF) mutually terminate the binding letter agreement for a proposed business combination transaction without liability or cost. The termination is due to the inability to satisfy a key condition of the transaction related to the approval of holders of Aleafia convertible debentures. RWB is considering all available options, while Aleafia's disinterested board members are exploring potential strategic alternatives to maximize value for stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Aleafia Health Inc. has announced that it will be paying interest in-kind on its Series A, B, and C secured debentures. Holders of debentures as of June 19, 2023, will receive additional debentures as payment of accrued interest. Trading in the debentures will be halted on June 22, 2023, and will resume on June 23, 2023, on an ex-distribution basis.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Red White & Bloom Brands Inc. (RWB) and Aleafia Health Inc. (Aleafia) have entered into a binding letter agreement for RWB to acquire Aleafia and its subsidiaries. The combined company is expected to represent C$138 million in trailing distribution and retail revenue and have approximately 3,000 retail locations in North America. The transaction is expected to result in annualized synergies of approximately C$10 million and provide opportunities for collaboration and growth in the cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none
Rhea-AI Summary
Aleafia Health Inc. has entered into a forbearance agreement with NE SPC II LP, extending the forbearance period under its loan agreement until June 5, 2023. The agreement is in light of ongoing negotiations for a potential refinancing. No decisions regarding refinancing have been made as of the date of this press release.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.26%
Tags
none
-
Rhea-AI Summary
Aleafia Health announces an amendment to its loan agreement with NE SPC, allowing for forbearance until May 31, 2023. The company is currently in breach of certain financial covenants and has initiated a strategic review process to explore potential alternatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-35.14%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.7%
Tags
Aleafia Health Inc.

OTC:ALEAF

ALEAF Rankings

ALEAF Stock Data

6.09M
397.10M
1.51%
0.02%
Other Food Crops Grown Under Cover
Agriculture, Forestry, Fishing and Hunting
Link
Canada
Concord

About ALEAF

aleafia health is an industry leading, vertically integrated and federally licensed canadian cannabis company offering cannabis health and wellness services and products in canada and in international markets. the company operates medical clinics, education centres and production facilities for the production and sale of cannabis. aleafia health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in canadian history. the company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays. aleafia health operates the largest national network of medical cannabis clinics and education centres staffed by mds, nurse practitioners and educators and operates internationally in three continents.